Dec 3, 2024 TNX-102 SL for Lead Indication: Fibromyalgia Additional Indication: Acute Stress Disorder
Sep 6, 2024 Using Synthetic Biology to Battle Mpox - Vaccine Symposium at the Department of Medical Microbiology & Immunology and the Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada
